Display Settings:

Format

Send to:

Choose Destination
    PLoS Pathog. 2009 Jun;5(6):e1000495. Epub 2009 Jun 26.

    Epigenetic regulation of HIV-1 latency by cytosine methylation.

    Source

    Gladstone Institute of Virology and Immunology, San Francisco, California, United States of America.

    Abstract

    Human immunodeficiency virus type 1 (HIV-1) persists in a latent state within resting CD4+ T cells of infected persons treated with highly active antiretroviral therapy (HAART). This reservoir must be eliminated for the clearance of infection. Using a cDNA library screen, we have identified methyl-CpG binding domain protein 2 (MBD2) as a regulator of HIV-1 latency. Two CpG islands flank the HIV-1 transcription start site and are methylated in latently infected Jurkat cells and primary CD4+ T cells. MBD2 and histone deacetylase 2 (HDAC2) are found at one of these CpG islands during latency. Inhibition of cytosine methylation with 5-aza-2'deoxycytidine (aza-CdR) abrogates recruitment of MBD2 and HDAC2. Furthermore, aza-CdR potently synergizes with the NF-kappaB activators prostratin or TNF-alpha to reactivate latent HIV-1. These observations confirm that cytosine methylation and MBD2 are epigenetic regulators of HIV-1 latency. Clearance of HIV-1 from infected persons may be enhanced by inclusion of DNA methylation inhibitors, such as aza-CdR, and NF-kappaB activators into current antiviral therapies.

    PMID:
    19557157
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2695767
    Free PMC Article

    Images from this publication.See all images (7) Free text

    Figure 1
    Figure 6
    Figure 3
    Figure 2
    Figure 7
    Figure 5
    Figure 4

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk